|
|
Post by raubtier on Oct 25, 2015 2:42:23 GMT -5
Maybe someone is interested:
- NAVB made the dual listing with TASE last month (September 8, 2015).
- NAVB is highly shorted.
I think the chart is very interesting.
|
|
|
|
Post by liane on Oct 25, 2015 5:24:16 GMT -5
And what does this have to do with MNKD?
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Oct 25, 2015 6:30:42 GMT -5
same question as Liane and how is the chart very interesting? delete thread?
|
|
|
|
Post by jonnykrush on Oct 25, 2015 7:02:21 GMT -5
Well, I actually went and looked at the chart and saw that it shot up from the $1.60s to the $2.40s immediately after the listing. If anything it is an indicator of what could happen to MNKD beginning later this week.
|
|
|
|
Post by raubtier on Oct 25, 2015 8:12:42 GMT -5
And what does this have to do with MNKD? - NAVB made the dual listing with TASE last month (September 8, 2015). - NAVB is highly shorted. see jonnykrush: Well, I actually went and looked at the chart and saw that it shot up from the $1.60s to the $2.40s immediately after the listing. If anything it is an indicator of what could happen to MNKD beginning later this week. |
|
|
|
Post by jpg on Oct 25, 2015 12:18:06 GMT -5
I am weary of these sort of blind comparisons...
|
|
|
|
Post by BlueCat on Oct 25, 2015 12:37:04 GMT -5
Blind comparison, maybe. And perhaps thread would be best placed as a comment under the thread regarding the listing.
However - not a useless comment. I think there has been plenty of speculation on what impact, if any, the dual listing may have on MNKD, stock price or otherwise.
Now Raubtier, what would be of great interest would be to do a small qualitative analysis, trend against a few biotechs or companies with similar profiles (aka: more than 1) and see if we can establish any trends.
Justa thought.
In any case, we will with time, definitely soon *know* the impact (or not) both short term and eventually long term, on MNKD.
|
|
|
|
Post by rrtzmd on Oct 25, 2015 19:17:17 GMT -5
Maybe someone is interested: - NAVB made the dual listing with TASE last month (September 8, 2015). - NAVB is highly shorted. I think the chart is very interesting. Well, I looked at the three month chart on NAVB: three month NAvB chartUp to August 24, it was trading about $1.60. It then began a steady and somewhat suspicious -- under the circumstances -- rise to about $2.00 when the Tel Aviv listing was announced 9/2. NAVB actually started trading in Tel Aviv on September 8. It closed at $2.28 that day. The highest it got was $2.41 on 9/18. And since the beginning of October, it has "dribbled" down to its closing price on Friday of $1.91. So the impact -- at least short term -- of actual trading in Tel Aviv doesn't appear too dramatic. |
|
|
|
Post by longstocking on Oct 25, 2015 21:00:09 GMT -5
Maybe someone is interested: - NAVB made the dual listing with TASE last month (September 8, 2015). - NAVB is highly shorted. I think the chart is very interesting. Well, I looked at the three month chart on NAVB: three month NAvB chartUp to August 24, it was trading about $1.60. It then began a steady and somewhat suspicious -- under the circumstances -- rise to about $2.00 when the Tel Aviv listing was announced 9/2. NAVB actually started trading in Tel Aviv on September 8. It closed at $2.28 that day. The highest it got was $2.41 on 9/18. And since the beginning of October, it has "dribbled" down to its closing price on Friday of $1.91. So the impact -- at least short term -- of actual trading in Tel Aviv doesn't appear too dramatic. And since listing on the Tel Aviv exchange is its only variable, this is an extremely useful indicator of what will happen to MNKD. Sheesh. |
|
|
|
Post by od on Oct 25, 2015 21:05:43 GMT -5
Amazing - Not one word about NAVB fundamentals. What does the company do? Sales projections? Short/medium/long term sales and earnings drivers? This thread may as well be discussing the best tables at the casino.
|
|
